BRCA2 Hypomorphic Missense Variants Confer Moderate Risks of Breast Cancer.

Hermela Shimelis, Pascal Guénel, Catharina Von Nicolai et al.|White Rose Research Online (University of Leeds, The University of Sheffield, University of York)|2017

Cited by 15